Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [ 18 F]FDG-PET imaging. Is it of value in asymptomatic patients?

MLA

Azizi, Amedeo A., et al. “Monitoring of Plexiform Neurofibroma in Children and Adolescents with Neurofibromatosis Type 1 by [ 18 F]FDG-PET Imaging. Is It of Value in Asymptomatic Patients?” Pediatric Blood & Cancer, vol. 65, no. 1, Jan. 2018. EBSCOhost, https://doi.org/10.1002/pbc.26733.

APA

Azizi, A. A., Slavc, I., Theisen, B. E., Rausch, I., Weber, M., Happak, W., Aszmann, O., Hojreh, A., Peyrl, A., Amann, G., Benkoe, T. M., Wadsak, W., Kasprian, G., Staudenherz, A., Hacker, M., & Traub-Weidinger, T. (2018). Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [ 18 F]FDG-PET imaging. Is it of value in asymptomatic patients? Pediatric Blood & Cancer, 65(1). https://doi.org/10.1002/pbc.26733

Chicago

Azizi, Amedeo A, Irene Slavc, Benjamin Emile Theisen, Ivo Rausch, Michael Weber, Wolfgang Happak, Oskar Aszmann, et al. 2018. “Monitoring of Plexiform Neurofibroma in Children and Adolescents with Neurofibromatosis Type 1 by [ 18 F]FDG-PET Imaging. Is It of Value in Asymptomatic Patients?” Pediatric Blood & Cancer 65 (1). doi:10.1002/pbc.26733.